The world’s first Visone® implant is a promising start
“Thanks to the efforts of a team of researchers from the Heart Institute, we conducted the world’s first implantation of the Visone system we have developed and we intend to further demonstrate the benefits of asymptomatic diaphragm stimulation (ADS) in patients with heart failure and lowered ejection fraction,” President and Chief Executive Officer of VisCardia Inc. Peter Bauer underlined in a report on the XIX national Congress of cardiologists of Ukraine, held in Kyiv on September 26-28.


